)
Visual
test
Haoxi Health Technology
Haoxi Health Technology (HAO) investor relations material
Haoxi Health Technology Registration Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Registration Filing summary10 Jun, 2025
Company overview and business model
Operates as a Cayman Islands holding company with operations in China via a wholly owned PRC subsidiary, focusing on online marketing solutions for healthcare advertisers.
Provides one-stop online marketing, specializing in short video ads through major Chinese platforms like Toutiao, Douyin, WeChat, and Weibo.
Has served approximately 2,000 advertisers since 2018, with a majority from the healthcare sector.
Utilizes proprietary data analysis software and maintains strong relationships with mainstream ad platforms.
Financial performance and metrics
Revenue for the six months ended December 31, 2024: $23.95 million; net loss: $232,533.
Fiscal year revenues: $48.52M (2024), $28.23M (2023), $16.16M (2022); net income: $1.29M (2024), $969,752 (2023), $244,587 (2022).
Key performance indicators include impressions, click-throughs, and conversions, with significant year-over-year growth in ad impressions and conversions.
Use of proceeds and capital allocation
Net proceeds will fund project development, business growth, working capital, and general corporate purposes.
May allocate funds to acquisitions or investments in technologies, products, or businesses, though no current commitments exist.
Management retains broad discretion over allocation of proceeds.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Haoxi Health Technology
- All AGM proposals, including share consolidation and director re-elections, passed with over 99% approval.HAO
AGM 202510 Jan 2026 - Registering up to $80M in securities, with strong revenue growth and high PRC regulatory risk.HAORegistration Filing16 Dec 2025
- FY2025 revenue fell 32% while net income surged to $3.88M, with ongoing regulatory and supplier risks.HAOQ4 202412 Dec 2025
- Raising $9.09M to expand healthcare-focused digital marketing in China, but faces regulatory and concentration risks.HAORegistration Filing29 Nov 2025
- IPO funds will drive growth and tech investment, but regulatory and supplier risks remain high.HAORegistration Filing29 Nov 2025
- Chinese healthcare-focused ad tech firm seeks $11.4M via Nasdaq unit offering, CEO retains control.HAORegistration Filing29 Nov 2025
- Offering 2,093,802 units at $5.97 each, the company targets healthcare ads but faces regulatory and concentration risks.HAORegistration Filing29 Nov 2025
- Rapid revenue growth, high regulatory risk, and CEO control define this complex offering.HAORegistration Filing29 Nov 2025
- Rapid revenue growth, but high supplier concentration and regulatory risks; $11.4M IPO with warrants.HAORegistration Filing29 Nov 2025
Haoxi Health Technology
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage